KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Receivables - Net (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Receivables - Net for 17 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 7.98% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 7.98% year-over-year, with the annual reading at $1.4 billion for FY2025, 7.98% up from the prior year.
  • Receivables - Net hit $1.4 billion in Q4 2025 for Quest Diagnostics, down from $1.5 billion in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $1.5 billion in Q3 2021 to a low of $1.2 billion in Q4 2022.
  • Historically, Receivables - Net has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2024.
  • Biggest five-year swings in Receivables - Net: skyrocketed 42.18% in 2021 and later dropped 16.9% in 2022.
  • Year by year, Receivables - Net stood at $1.4 billion in 2021, then dropped by 16.9% to $1.2 billion in 2022, then grew by 1.26% to $1.2 billion in 2023, then rose by 7.77% to $1.3 billion in 2024, then rose by 7.98% to $1.4 billion in 2025.
  • Business Quant data shows Receivables - Net for DGX at $1.4 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.4 billion in Q2 2025.